his study investigates the effectiveness of three specific biological markers (biomarkers) in the blood-the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)-to better diagnose and monitor preeclampsia. Preeclampsia is a serious pregnancy complication characterized by high blood pressure and potential organ damage that affects 2-8% of pregnancies worldwide
Pregnant women between 20 and 36 weeks of gestation
Age between 18 and 45 years
Attending the antenatal clinic at the study site
Chronic hypertension
Renal disease
Diabetes mellitus
Multiple gestations
Ammar Jassim Abed
Lead sponsor
University of Thi-Qar
Sponsor institution